JPMorgan Chase & Co. Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $64.00
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price cut by JPMorgan Chase & Co. from $72.00 to $64.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the stock. A number of other equities research analysts have also weighed in on APLS. HC Wainwright cut […]
More Stories
CMS Energy (NYSE:CMS) Stock Rating Upgraded by StockNews.com
CMS Energy (NYSE:CMS – Get Free Report) was upgraded by equities researchers at StockNews.com from a “sell” rating to a...
Equities Research Analysts’ Upgrades for January 15th (AIT, ALLY, BH, CMS, CZWI, EML, HWBK, LIVN, NNI, PFLT)
Equities Research Analysts’ upgrades for Wednesday, January 15th: Applied Industrial Technologies (NYSE:AIT) was upgraded by analysts at StockNews.com from a...
Controladora Vuela Compañía de Aviación (NYSE:VLRS) Upgraded by StockNews.com to “Strong-Buy” Rating
Controladora Vuela Compañía de Aviación (NYSE:VLRS – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy”...
York Traditions Bank (OTCMKTS:YRKB) Stock Price Crosses Below Fifty Day Moving Average – Should You Sell?
York Traditions Bank (OTCMKTS:YRKB – Get Free Report) shares crossed below its 50-day moving average during trading on Monday ....
Telkom SA SOC (OTCMKTS:TLKGY) Share Price Passes Above 50-Day Moving Average – Should You Sell?
Telkom SA SOC Ltd (OTCMKTS:TLKGY – Get Free Report)’s stock price crossed above its 50 day moving average during trading...
Stellar AfricaGold (CVE:SPX) Trading Up 53.8% – Should You Buy?
Stellar AfricaGold Inc. (CVE:SPX – Get Free Report)’s stock price shot up 53.8% during mid-day trading on Wednesday . The...